These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11758772)

  • 21. Facilitation of pulmonary insulin absorption by H-MAP: pharmacokinetics and pharmacodynamics in rats.
    Suarez S; Garcia-Contreras L; Sarubbi D; Flanders E; O'Toole D; Smart J; Hickey AJ
    Pharm Res; 2001 Dec; 18(12):1677-84. PubMed ID: 11785686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphatic transport of Methylnortestosterone undecanoate (MU) and the bioavailability of methylnortestosterone are highly sensitive to the mass of coadministered lipid after oral administration of MU.
    White KL; Nguyen G; Charman WN; Edwards GA; Faassen WA; Porter CJ
    J Pharmacol Exp Ther; 2009 Nov; 331(2):700-9. PubMed ID: 19696095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PEGylation does not significantly change the initial intravenous or subcutaneous pharmacokinetics or lymphatic exposure of trastuzumab in rats but increases plasma clearance after subcutaneous administration.
    Chan LJ; Bulitta JB; Ascher DB; Haynes JM; McLeod VM; Porter CJ; Williams CC; Kaminskas LM
    Mol Pharm; 2015 Mar; 12(3):794-809. PubMed ID: 25644368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique.
    Cernea S; Kidron M; Wohlgelernter J; Modi P; Raz I
    Clin Ther; 2004 Dec; 26(12):2084-91. PubMed ID: 15823772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Removal of interstitial hyaluronan with recombinant human hyaluronidase improves the systemic and lymphatic uptake of cetuximab in rats.
    Styles IK; Feeney OM; Nguyen TH; Brundel DHS; Kang DW; Clift R; McIntosh MP; Porter CJH
    J Control Release; 2019 Dec; 315():85-96. PubMed ID: 31655131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability of a commercial formulation of ivermectin after subcutaneous administration to sheep.
    Canga AG; Sahagun A; Diez MJ; Fernandez N; Sierra M; Garcia JJ
    Am J Vet Res; 2007 Jan; 68(1):101-6. PubMed ID: 17199426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intranasal bioavailability of insulin from carbopol-based gel spray in rabbits.
    Najafabadi AR; Moslemi P; Tajerzadeh H
    Drug Deliv; 2004; 11(5):295-300. PubMed ID: 15742554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of intestinal lymphatic transport on the systemic exposure and brain deposition of a novel highly lipophilic compound with structural similarity to cholesterol.
    Caliph SM; Faassen FW; Porter CJ
    J Pharm Pharmacol; 2014 Oct; 66(10):1377-87. PubMed ID: 24821499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Porcine and human insulin absorption from subcutaneous tissues in normal and insulin-dependent diabetic subjects: a deconvolution-based approach.
    Nosadini R; De Kreutzenberg S; Duner E; Iori E; Avogaro A; Trevisan R; Fioretto P; Doria A; Merkel C; Cobelli C
    J Clin Endocrinol Metab; 1988 Sep; 67(3):551-9. PubMed ID: 3045144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability and bioeffectiveness of subcutaneous human insulin and two of its analogs--LysB28ProB29-human insulin and AspB10LysB28ProB29-human insulin--assessed in a conscious pig model.
    Radziuk JM; Davies JC; Pye WS; Shields JE; DiMarchi RD; Chance RE
    Diabetes; 1997 Apr; 46(4):548-56. PubMed ID: 9075793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimate the insulin absorption in diabetic patients on peritoneal dialysis.
    Pantsulaia T; Chokhonelidze I; Lomitashvili T
    Georgian Med News; 2006 Nov; (140):28-30. PubMed ID: 17179582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes.
    Pettis RJ; Hirsch L; Kapitza C; Nosek L; Hövelmann U; Kurth HJ; Sutter DE; Harvey NG; Heinemann L
    Diabetes Technol Ther; 2011 Apr; 13(4):443-50. PubMed ID: 21355716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the intestinal lymphatics in the absorption of two highly lipophilic cholesterol ester transfer protein inhibitors (CP524,515 and CP532,623).
    Trevaskis NL; McEvoy CL; McIntosh MP; Edwards GA; Shanker RM; Charman WN; Porter CJ
    Pharm Res; 2010 May; 27(5):878-93. PubMed ID: 20221896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 125I used for labelling of proteins in an absorption model changes the absorption rate of insulin aspart.
    Sohoel A; Plum A; Frokjaer S; Thygesen P
    Int J Pharm; 2007 Feb; 330(1-2):114-20. PubMed ID: 17070660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-response relationships of inhaled insulin delivered via the Aerodose insulin inhaler and subcutaneously injected insulin in patients with type 2 diabetes.
    Kim D; Mudaliar S; Chinnapongse S; Chu N; Boies SM; Davis T; Perera AD; Fishman RS; Shapiro DA; Henry R
    Diabetes Care; 2003 Oct; 26(10):2842-7. PubMed ID: 14514589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the Monoclonal Antibody Disposition after Subcutaneous Administration using a Minimal Physiologically based Pharmacokinetic Model.
    Varkhede N; Forrest ML
    J Pharm Pharm Sci; 2018; 21(1s):130s-148s. PubMed ID: 30011390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human interferon alpha-2a: delivery to lymphoid tissue by selected modes of application.
    Supersaxo A; Hein W; Gallati H; Steffen H
    Pharm Res; 1988 Aug; 5(8):472-6. PubMed ID: 3244653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor.
    Hauss DJ; Fogal SE; Ficorilli JV; Price CA; Roy T; Jayaraj AA; Keirns JJ
    J Pharm Sci; 1998 Feb; 87(2):164-9. PubMed ID: 9519148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin disposition in the lung following oral inhalation in humans : a meta-analysis of its pharmacokinetics.
    Sakagami M
    Clin Pharmacokinet; 2004; 43(8):539-52. PubMed ID: 15170368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro.
    Rave KM; Nosek L; de la Peña A; Seger M; Ernest CS; Heinemann L; Batycky RP; Muchmore DB
    Diabetes Care; 2005 Oct; 28(10):2400-5. PubMed ID: 16186270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.